Does Epitalon work?
Not properly: animal or lab studies, or small uncontrolled human reports. The one 266-person study tested a different extract and had unclear methods.
The anti-aging claim rests on rodent and fruit-fly lifespan studies, monkey hormone-rhythm studies and cell-culture telomerase work, nearly all from the St Petersburg group that designed the peptide. 1235 The only human mortality data concern Epithalamin, a crude pineal extract, in a 266-person study without a described randomization or blinding, so human evidence for epitalon itself is essentially absent. 7
In 2003 the Khavinson group reported on 266 elderly people. They got Epithalamin and a thymus extract over several years. Deaths in the Epithalamin group were 1.6 to 1.8 times lower than in controls. The paper is indexed as a randomized trial. But it does not describe randomization, allocation concealment or blinding. It does not describe the comparison groups. No independent group has replicated it. It studied the extract, not epitalon. 7
For epitalon itself, the group's reviews mention better sight in patients with retinitis pigmentosa. They also mention normal melatonin rhythms. But these are brief summary lines. They are not controlled trials with published methods. 1
Evidence checklist
- Randomised controlled trial No RCT of epitalon in people
- Human study over 100 people 266-person study, but of a different extract
- More than one research group Nearly all work from one St Petersburg group
- Clinical outcomes, not surrogate markers Mortality data are for Epithalamin, unreplicated
- Human safety data beyond case reports No systematic safety monitoring
More on Epitalon
Citations
- Anisimov and Khavinson 2002, Neuro Endocrinology Letters: peptides and ageing pubmed.ncbi.nlm.nih.gov
- Khavinson 2003, Bulletin of Experimental Biology and Medicine: epitalon induces telomerase activity in human somatic cells doi.org
- Khavinson 2002, Bulletin of Experimental Biology and Medicine: epitalon and lifespan in animals doi.org
- AJMC 2026: FDA panel backs six peptides for compounding ajmc.com
- 2025, Biogerontology: epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity pubmed.ncbi.nlm.nih.gov
- FDA 2026: Pharmacy Compounding Advisory Committee briefing document on epitalon fda.gov
- Khavinson and Morozov 2003, Neuro Endocrinology Letters: peptides of pineal gland and thymus prolong human life pubmed.ncbi.nlm.nih.gov
- DEA: controlled substances alphabetical list deadiversion.usdoj.gov
- FDA: bulk drug substances nominated for use in compounding under section 503A, Category 1 fda.gov
- STAT 2026: FDA peptide compounding panel backs epitalon, rejects emideltide statnews.com
- 2024, Peptides: mitochondrial-derived peptides, antidiabetic functions and evolutionary perspectives pubmed.ncbi.nlm.nih.gov
- HHS 2026: Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, with appendices A and B hhs.gov
- Federal Register 2026: notice of availability of the HHS peptide enforcement discretion policy, document 2026-22192, docket HHS-OASH-2026-0496 federalregister.gov
- Associated Press via CNN, 28 October 2026: FDA scientists opposed the move to ease peptide access edition.cnn.com
Reference information only, not medical advice. Drawn from the Epitalon article, fact-checked against the cited sources. No dosing anywhere on this site.